Format

Send to

Choose Destination
J Thorac Oncol. 2016 Mar;11(3):284-6. doi: 10.1016/j.jtho.2016.01.003.

The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?

Author information

1
Maastro Clinic, Maastricht, The Netherlands; Department of Radiation Oncology, Katholieke Universiteit Leuven, Leuven, Belgium. Electronic address: dirk.deruysscher@maastro.nl.
2
Department of Pulmonology, University Hospitals Leuven/Katholieke Universiteit Leuven, Belgium.
3
Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
4
Department of Thoracic Surgery, University Hospitals Leuven/Katholieke Universiteit Leuven, Leuven, Belgium.
5
Department of Pulmonology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
PMID:
26922920
DOI:
10.1016/j.jtho.2016.01.003
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center